Tag | Content |
---|
EnhancerAtlas ID | HS102-10798 |
Organism | Homo sapiens |
Tissue/cell | HuCCT1 |
Coordinate | chr17:74704620-74706680 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
ZBTB33 | MA0527.1 | chr17:74705329-74705344 | CTCCCGCGAGACCTC | + | 6.42 | ZNF263 | MA0528.1 | chr17:74706053-74706074 | GGGGGAGTGGGGGTAGGAGGG | + | 6.25 | Zfx | MA0146.2 | chr17:74706591-74706605 | GAGGCCGCGGCCCC | - | 6.59 |
|
| Number of super-enhancer constituents: 29 | ID | Coordinate | Tissue/cell |
SE_00954 | chr17:74703516-74707876 | Adrenal_Gland | SE_01807 | chr17:74703603-74707092 | Aorta | SE_02729 | chr17:74704492-74707098 | Astrocytes | SE_04253 | chr17:74703497-74707109 | Brain_Anterior_Caudate | SE_26767 | chr17:74703420-74707961 | Esophagus | SE_28742 | chr17:74703707-74706827 | Fetal_Intestine_Large | SE_29859 | chr17:74703313-74708323 | Fetal_Muscle | SE_37069 | chr17:74703353-74708382 | HSMMtube | SE_39328 | chr17:74703858-74707032 | IMR90 | SE_40719 | chr17:74701539-74708204 | Left_Ventricle | SE_42350 | chr17:74703494-74708386 | Lung | SE_44481 | chr17:74703731-74706862 | NHDF-Ad | SE_45218 | chr17:74704075-74706878 | NHLF | SE_45997 | chr17:74703535-74707090 | Osteoblasts | SE_46847 | chr17:74704708-74707799 | Ovary | SE_48029 | chr17:74704698-74707767 | Pancreas | SE_48607 | chr17:74703319-74708389 | Right_Atrium | SE_49540 | chr17:74703625-74707767 | Right_Ventricle | SE_50328 | chr17:74703705-74707970 | Sigmoid_Colon | SE_51951 | chr17:74703990-74707054 | Skeletal_Muscle_Myoblast | SE_56072 | chr17:74703596-74708429 | u87 | SE_63747 | chr17:74703781-74707062 | HSMM | SE_67575 | chr17:74703596-74708429 | u87 | SE_68515 | chr17:74692690-74734995 | TC71 | SE_68516 | chr17:74692690-74734995 | TC71 | SE_68517 | chr17:74692690-74734995 | TC71 | SE_68518 | chr17:74692690-74734995 | TC71 | SE_68519 | chr17:74692690-74734995 | TC71 | SE_68520 | chr17:74692690-74734995 | TC71 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | AAAGCACTGG AAGCTCTTGG AAACGCTGGA GTCCACTTCA GGACAATTTG TTTTCCTTTC 60 TTTTTTTTCT TGTCACTGAC TCGAAGCTCA TCAAGACAAT TTCTAAGCAG CTTCTTAGGT 120 TAATGCCACC ACTGGGAGTG GGTGGGATGA CACAATATCT GTGTCCCCAC AGCACCTGGC 180 TTAATGTTTG CAGGCAGGAG TTTTGGGGGA GCTTTGGCCA GCTCAGGAAG GCCTGGGGAC 240 TTGAACCCAA AGGGGAAGGG CACTGACTTC AATTGAATTC TCCTGTGGGG TGGGTTCTCT 300 CTGGAGGGTG CCTTAGCGGG AGGACAGACA CAAGCCTCAA GTCATCCTCA CTGGCACCTA 360 TGTCATGGGG GCTGCCTGGC ACGCGAACCC CCATACTGCC TTGTCCTTCA GAGCACCCAT 420 TCAGCTTCAG AGGACGTGCA TTCACCCAGA CAGTGGCAAA TTATGCGAGT GGCCCTATTT 480 AAACACCACT GAACCTATTC CTGTAGGTAC CATGTGCTGA GAGCCGAAAG CCTTGTAGAA 540 AGTTCTTTAA GCGCTGTGCC CCACAGGATT GAGCTAAGAC AGGGCGCCGC TAAAGGACAT 600 TTTGCACTTC AGTCCAGAGC CTGGTGTGGG TGATAAAGGG CCAGCCCTGT AAGGCCAGGA 660 CTGACTGAGT GTGCATGACG GCTCCAGAAC TGTCTAAAGG CCTCTCCTGC TCCCGCGAGA 720 CCTCGATGGA GGCAGGAATC CCAAATATGG GAGCAAACAC AACAGATCAG CACATGTCCA 780 AACCGCGCCC CCTCCACCAT CACCGCGTGA GGTCTGGAAG CCCACCCCAA GCAAGAACGG 840 CAGGGCCTGC CCCTGCTCCA CCCCATTAAA TGTGGCTGGT TAGAATCCTC TCTAATGACA 900 CAATTAGTCA CCCACTTGTC AAGCAAAGCG CCTGCTCAGA GGGGGTCTGG CGCACTTACT 960 CAGCAAAGAG AAATGCCTCT GAGCACAGCC TGGCTGCCTC CTCCTCCCCC GAAGGGCTTC 1020 TCTCCAGGGT AAACCATTGT GTCCAGCACA GGACAGAGTG GGCACGCAGA CACGCAGGCA 1080 CGCTGACAAT GCGCATCCCG GCTCTCCTCC CTTCCAAGAA AAGGAGCTCA GGGGTAAGAA 1140 CAAGGGATTA CAATCCGACT CGGAGACCCT GGCGGTGGCC TGGACCGGCC AAGCGTGGTG 1200 AACTCCAGGG AACATGGGCA CACAGTGTAG GGGCTGGGAT GAGTGGATGA GGGAAATCCG 1260 ACTCCTCTCA GATATCCACA GGCAGGACAA GGTGGCCAAG GCCGAGCTGA TGGACAGCAT 1320 GGCGGGAGGC CTGGGGCAGA GGCAGGGAGG GCCGCTTTGG GGTGCTCACT GGTGCTCCAG 1380 GAGGGCTTTA TCCTGCATCT TCACTCCATC CAGGCCCAGC TTACCTACAA CCCGGGGGAG 1440 TGGGGGTAGG AGGGTGTTAG ATGTGTAGCT TGAAAACGAC AATAAAAAGG ACTGCTGGGA 1500 TCGGGTGCCT TTTCTTTCAG TCCCAGCCCA CGGGCTTCAC AAAACGCCAC AGCACTGACT 1560 CTGAAATCTG GACTTCAAAT TGGCTGAAAA AGAAAAGCCA GCTTTCCTCC CTCGCCCCCC 1620 GAAAGTCCTA CTTTTTAAAC ATCAAGATAA CTCTCATGGC AGGCCTGGAA ATAAGCCACA 1680 GGCACGTGGA TTTGGGAACC GGTGGGCGGG AGGGGTCAGA AGTGGGTGAG GAGCAAAATT 1740 CCAAGCCCTG GTCCCGAGGC CTGGGAGCCA GCAGCTGCGG AGCACGCCCT GGGCTGGGAG 1800 AGGCCGAGGG GAGGGGAGAG CAAAACACCT CCAAACAAAC TCCTTCGGGC TCGCCCCTCG 1860 CCACACTTTC TGGGGGAGGG CGGCGAGTTT GCGGGGCTGC GGCTTAGCAT GGCGGGACCT 1920 GCATTTCCTG CGGGCCGCGG GTTCTGCGCT TCCTGGGGGC AGCCTGGGCT GGAGGCCGCG 1980 GCCCCGCTCC CTGGCTCGGC GGGGAACGGC AGCGGCAGCC GGAGCCCCGG GGGTGGGGAG 2040 GGGGCCGCGA GGGCCCCGGT 2060
|